S100B and cancer: This evidence is also supported by other studies, showing that in colon cancer patients, an increased immunoreactivity for S100B protein is a reliable prognostic factor of recurrence after curative resection.38 S100B‐driven pro‐malignant microenvironment may thus precede cancer development, rather than being its consequence.